AstraZeneca PLC ADR (AZN): Price and Financial Metrics

AZN POWR Grades

• Sentiment is the dimension where AZN ranks best; there it ranks ahead of 92.1% of US stocks.
• AZN's strongest trending metric is Quality; it's been moving down over the last 179 days.
• AZN ranks lowest in Momentum; there it ranks in the 8th percentile.

AZN Stock Summary

• With a market capitalization of $204,365,947,714, Astrazeneca Plc has a greater market value than 98.91% of US stocks.
• With a price/earnings ratio of 1,777.1, Astrazeneca Plc P/E ratio is greater than that of about 99.45% of stocks in our set with positive earnings.
• In terms of volatility of its share price, AZN is more volatile than only 5.65% of stocks we're observing.
• Stocks with similar financial metrics, market capitalization, and price volatility to Astrazeneca Plc are NVS, BMY, MRK, NFLX, and TXN.
• AZN's SEC filings can be seen here. And to visit Astrazeneca Plc's official web site, go to www.astrazeneca.com.

AZN Valuation Summary

• AZN's EV/EBIT ratio is 29.1; this is 0.68% lower than that of the median Healthcare stock.
• Over the past 243 months, AZN's price/sales ratio has gone up 2.7.
• Over the past 243 months, AZN's price/sales ratio has gone up 2.7.

Below are key valuation metrics over time for AZN.

AZN Growth Metrics

Its 3 year price growth rate is now at 31.18%.
• Its 2 year cash and equivalents growth rate is now at 13.58%.
• The 5 year price growth rate now stands at 75.14%.

AZN's revenue has moved up $12,651,000,000 over the prior 70 months.

The table below shows AZN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	37,417	5,963	115
2021-12-31	37,417	5,963	115
2021-09-30	32,816	6,343	1,466
2021-06-30	29,528	6,446	3,768
2021-03-31	27,583	6,594	3,956
2020-12-31	26,617	4,799	3,144

AZN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AZN has a Quality Grade of B, ranking ahead of 78.56% of graded US stocks.
• AZN's asset turnover comes in at 0.438 -- ranking 104th of 681 Pharmaceutical Products stocks.
• CLVS, HSKA, and FLXN are the stocks whose asset turnover ratios are most correlated with AZN.

The table below shows AZN's key quality metrics over time.